A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

Clinical trial NCT01191255 · COMPLETED

Trial details

NCT number: NCT01191255
Sponsor: Keryx Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphosphatemia Kidney Failure

Start date: 2010-10-01
Primary completion: 2013-01-01
Enrollment: 441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.